Fig. 4From: m6A RNA methylation regulator-based signature for prognostic prediction and its potential immunological role in uterine corpus endometrial carcinomaThe mRNA signature associated with the m6A trait. A The profile of the LASSO coefficients. B The partial likelihood of deviance is shown against log (Lambda). At the value fitting 10-fold cross-validation, a vertical line was drawn. C Forest plots of the prognostic ability of the nine m6A-related mRNAs are included in the prognostic signature. Time-dependent ROC curves and Kaplan-Meier survival analysis between UCEC patients with high- and low-risk depend upon our mRNA signature. (D, E) Training cohort. (G, H) Testing cohort. We used AUCs at 1, 3, 5, and 7 years to assess prognostic accuracy and calculated P values using the log-rank test. F Gene Ontology (GO) enrichment of the m6A signatureBack to article page